Report Feature
The future of the injectable drug delivery market looks promising with opportunities in the hospitals, clinics, and home care. The global injectable drug delivery market is expected to grow with a CA
GR of 11% from 2019 to 2024. The major drivers for this market are rising prevalence of chronic diseases, increase in demand for self-injection devices, growth in the biologics market, and technological advancements.A report of more than 150-pages is developed to help in your business decisions. Sample figures with some insights are shown below. To learn the scope of, benefits, companies researched and other details of injectable drug delivery market report download the report brochure
The study includes the injectable drug delivery market size and forecast for the global injectable drug delivery market through 2024, segmented by product type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region as follows:
By Product Type [$M shipment analysis for 2013 – 2024]:
- Devices
- Formulations
By Formulation Packaging [$M shipment analysis for 2013 – 2024]:
- Ampules
- Vials
- Cartridges
- Bottles
By Therapeutic Application [$M shipment analysis for 2013 – 2024]:
- Auto-immune diseases
- Hormonal Disorders
- Orphan Diseases
- Oncology
- Others
By Usage Pattern [$M shipment analysis for 2013 – 2024]:
- Curative Care
- Immunization
- Other Usage Pattern
By Site of Administration [$M shipment analysis for 2013 – 2024]:
- Skin
- Circulatory/Musculoskeletal
- Organs
- Central Nervous System
By Distribution Channel [$M shipment analysis for 2013 – 2024]:
- Hospitals
- Retail Pharmacy Stores
By Facility of Use [$M shipment analysis for 2013 – 2024]:
- Hospitals and Clinics
- Home Care Settings
- Other Facilities of Use
By Region [$M shipment analysis for 2013 – 2024]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
-
Asia-Pacific
- China
- India
- Japan
-
Rest of the World (ROW)
- Brazil
Some of the injectable drug delivery companies profiled in this report include Becton, Dickinson and Company, Baxter International, Pfizer, Gerresheimer, Schott, Eli Lilly and Company, and Terumo are among the major manufacturers of injectable drug delivery market.
Some of the features of "Global Injectable Drug Delivery Market 2019-2024: Trends, Forecast, and Opportunity Analysis" include
- Market size estimates:Global injectable drug delivery market size estimation in terms of value ($M) shipment.
- Trend and forecast analysis:Market trend (2013-2018) and forecast (2019-2024) by segments and region.
- Segmentation analysis:Global market size by product type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and region.
- Regional analysis:Global injectable drug delivery market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth opportunities:Analysis on growth opportunities in different applications and regions for injectable drug delivery in the global injectable drug delivery market.
- Strategic analysis:This includes M&A, new product development, and competitive landscape for injectable drug delivery in the global injectable drug delivery market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
Table of Contents
1. Executive Summary 2. Market Background and Classifications 2.1. Introduction, Background, and Classifications 2.2. Supply Chain 2.3. Industry Drivers and Challenges
5. Competitor Analysis 5.1: Product Portfolio Analysis 5.2: Market Share Analysis 5.3: Operational Integration 5.4: Geographical Reach 5.5: Porter’s Five Forces Analysis
7. Company Profiles of Leading Players 7.1: Becton, Dickinson And Company 7.2: Baxter International 7.3: Pfizer 7.4: Gerresheimer 7.5: Schott 7.6: Eli Lilly And Company 7.7: Terumo Corporation
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
Key Questions
- • What are some of the most promising potential, high-growth opportunities for the global injectable drug delivery market by product type (devices and formulations), by formulation (ampules, vials, cartridges, and bottles),therapeutic application ( auto-immune diseases, hormonal disorders, orphan diseases, oncology and others), usage pattern (curative care, immunization and others), site of administration (skin, circulatory/ musculoskeletal, organs, and central nervous system), distribution channel (hospitals, and retail pharmacy stores), facility of use (hospitals & clinics, and home care settings), and region (North America, Europe, Asia-Pacific, and Rest of the World (ROW))?
- • Which segments will grow at a faster pace and why?
- • Which regions will grow at a faster pace and why?
- • What are the key factors affecting market dynamics? What are the drivers and challenges of the injectable drug delivery market?
- • What are the business risks and threats to the injectable drug delivery market?
- • What are emerging trends in this injectable drug delivery market and the reasons behind them?
- • What are some changing demands of customers in the injectable drug delivery market?
- • What are the new developments in the injectable drug delivery market? Which companies are leading these developments?
- • Who are the major players in this injectable drug delivery market? What strategic initiatives are being implemented by key players for business growth?
- • What are some of the competitive products and processes in this injectable drug delivery area and how big of a threat do they pose for loss of market share via material or product substitution?
- • What M & A activities have taken place in the last 5 years in this injectable drug delivery market?
